| 6 | 1/1 | 返回列表 |
| 查看: 1261 | 回復: 5 | ||
| 本帖產(chǎn)生 1 個 翻譯EPI ,點擊這里進行查看 | ||
polarmouse鐵蟲 (初入文壇)
|
[求助]
求兩段翻譯,非常緊急,感激涕零
|
|
|
In open-label, randomized, three-period, three-treatment crossover studies, 10 subjects received 10 mg A, 45 mg B or the combination, while20 subjects received 20 mg A, 1000 mg C or the combination. In an open-label, randomized, five-period, five-treatment, unbalanced crossover study, 12 subjects first received 20 mg A, 4 mg D or the combination, and afterward 100 mg sitagliptin or sitagliptin plus 20 mg A. Blood samples were taken over 72 h of each treatmentperiod. Lack of PK interaction was defined as the ratio of geometric means and 90% confidence interval (CI) for combination:monotherapy being within the range of 0.80–1.25 。 Co-administration of A withB, C or D had no effect on A maximum plasma concentration (Cmax) or area under the plasma concentration-time curve (AUC). Similarly, A did not affect the Cmax or AUC for the co-administered drug, except for slight extensions of the 90% CI for the ratio of geometric means for B AUC (upper limit 1.29) andC Cmax (lower limit 0.75). All monotherapies and combination therapies were well tolerated. A can be co-administered with B、C、Dwithout dose adjustment of either drug |
鐵蟲 (初入文壇)
鐵蟲 (初入文壇)
鐵蟲 (初入文壇)
鐵桿木蟲 (職業(yè)作家)
T_T
|
In open-label, randomized, three-period, three-treatment crossover studies, 10 subjects received 10 mg A, 45 mg B or the combination, while20 subjects received 20 mg A, 1000 mg C or the combination. In an open-label, randomized, five-period, five-treatment, unbalanced crossover study, 12 subjects first received 20 mg A, 4 mg D or the combination, and afterward 100 mg sitagliptin or sitagliptin plus 20 mg A。 在進行持續(xù)三個周期,隨機開放標記的三個處理交叉治療研究當中,10個樣本中加入10mg的A,45mg的B或者二者的混合物,另外20個樣本中加入20mg的A、1000mg的C或者二者的混合物。在另一個隨機開放標記,維持5個周期的5個交叉不平衡處理研究當中,首先向12個樣本中加入20mg A,4mg D或者二者混合物,然后再加入100mg西他列汀或加有20mgA的西他列汀。 |
鐵桿木蟲 (職業(yè)作家)
T_T
|
Blood samples were taken over 72 h of each treatment period. Lack of PK interaction was defined as the ratio of geometric means and 90% confidence interval (CI) for combination:monotherapy being within the range of 0.80–1.25 。 每個處理周期72小時之后將血液樣本取出。根據(jù)幾何方法和混合物90%置信區(qū)間(在0.8-1.25范圍內(nèi)的單一治療)的比值來判定交叉反應中是否缺乏PK。 |
| 6 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 材料與化工085600,總分304,本科有兩篇sci參與,求調(diào)劑 +10 | 幸運的醬醬 2026-03-22 | 12/600 |
|
|---|---|---|---|---|
|
[考研] 277跪求調(diào)劑 +4 | 1915668 2026-03-27 | 7/350 |
|
|
[考研] 287求調(diào)劑 +10 | land xuxu 2026-03-26 | 10/500 |
|
|
[考研] 085600,材料與化工321分,求調(diào)劑 +9 | 大饞小子 2026-03-27 | 9/450 |
|
|
[材料工程] 一志愿C9材料與化工專業(yè)總分300求調(diào)劑 +7 | 曼111 2026-03-24 | 8/400 |
|
|
[考研]
|
孅華 2026-03-22 | 16/800 |
|
|
[考研] 276求調(diào)劑。有半年電池和半年高分子實習經(jīng)歷 +10 | 材料學257求調(diào)劑 2026-03-23 | 11/550 |
|
|
[考研] 求調(diào)劑 +6 | 林之夕 2026-03-24 | 6/300 |
|
|
[考研] 材料調(diào)劑 +8 | 匹克i 2026-03-23 | 8/400 |
|
|
[考研] 071000生物學求調(diào)劑,初試成績343 +6 | 小小甜面團 2026-03-25 | 6/300 |
|
|
[考研] 333求調(diào)劑 +6 | wfh030413@ 2026-03-23 | 6/300 |
|
|
[考研] 321求調(diào)劑 +6 | wasdssaa 2026-03-26 | 6/300 |
|
|
[考研]
|
平樂樂樂 2026-03-26 | 4/200 |
|
|
[考研] 北科281學碩材料求調(diào)劑 +17 | tcxiaoxx 2026-03-20 | 19/950 |
|
|
[考研] 334分 一志愿武理 材料求調(diào)劑 +4 | 李李不服輸 2026-03-26 | 4/200 |
|
|
[考研] 332求調(diào)劑 +6 | 032500 2026-03-25 | 6/300 |
|
|
[考研] 一志愿南航 335分 | 0856材料化工 | GPA 4.07 | 有科研經(jīng)歷 +6 | cccchenso 2026-03-23 | 6/300 |
|
|
[考研] 化工專碩求調(diào)劑 +3 | question挽風 2026-03-24 | 3/150 |
|
|
[考研] 材料/農(nóng)業(yè)專業(yè),07/08開頭均可,過線就行 +3 | 呵唔哦豁 2026-03-23 | 4/200 |
|
|
[考研] 求老師收我 +3 | zzh16938784 2026-03-23 | 3/150 |
|